Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
UTI Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesEQ - SUN PHARMACEUTICALS INDUSTRIES10.7308725000129.1153
Domestic EquitiesEQ - CIPLA LTD.5.745145066069.1267
Domestic EquitiesEQ - AJANTA PHARMA LTD.4.849419304758.3494
Domestic EquitiesEQ - DR REDDYS LABORATORIES LTD.4.698747023456.5362
Domestic EquitiesEQ - GLENMARK PHARMACEUTICALS LTD.3.929730931147.2828
Domestic EquitiesEQ - GLAND PHARMA LTD.3.846726630646.2840
Domestic EquitiesEQ - APOLLO HOSPITALS ENTERPRISE LT3.40536000040.9734
Domestic EquitiesEQ - FORTIS HEALTHCARE LTD.3.351061165840.3205
Domestic EquitiesEQ - PROCTOR & GAMBLE HEALTH LTD3.18407400038.3102
Domestic EquitiesEQ - DIVIS LABORATORIES LTD.3.15406148037.9498
Domestic EquitiesEQ - KRISHNA INSTITUTE OF MEDI SCIE3.086863000037.1417
Domestic EquitiesEQ - ERIS LIFESCIENCES LTD2.992325000036.0038
Domestic EquitiesEQ - ALKEM LABORATORIES LTD2.95536302135.5593
Domestic EquitiesEQ - SUVEN PHARMACEUTICALS LTD2.943027118335.4111
Domestic EquitiesEQ - AUROBINDO PHARMA LTD.2.623425000031.5650
Domestic EquitiesEQ - CAPLIN POINT LABORATORIES LTD2.555514000030.7489
Domestic EquitiesEQ - TORRENT PHARMACEUTICALS LTD.2.34838500028.2557
Domestic EquitiesEQ - EMCURE PHARMACEUTICALS LTD2.268920000027.3000
Domestic EquitiesEQ - METROPOLIS HEALTHCARE LTD2.034211428624.4755
Domestic EquitiesEQ - ASTER DM HEALTHCARE LTD2.033148930624.4629
Domestic EquitiesEQ - ZYDUS LIFESCIENCES LTD1.969024526423.6913
Domestic EquitiesEQ - MARKSANS PHARMA LTD.1.709260000020.5650
Domestic EquitiesEQ- JUPITER LIFE LINE HOSPITALS LTD1.693913474420.3814
Domestic EquitiesEQ - SEQUENT SCIENTIFIC LTD1.6898100000020.3320
Domestic EquitiesEQ - PFIZER LIMITED1.64783731619.8269
Domestic EquitiesEQ - WINDLAS BIOTEC LTD1.576817355818.9725
Domestic EquitiesEQ - VIJAYA DIAGNOSTIC CENTRE LTD1.455915015117.5174
Domestic EquitiesEQ - AMI ORGANICS LTD1.42488000017.1436
Domestic EquitiesEQ - SYNGENE INTERNATIONAL LTD.1.407418000016.9344
Domestic EquitiesEQ - MAX HEALTHCARE INSTITUTE LTD1.282615751215.4322
Domestic EquitiesEQ - IPCA LABORATORIES LTD.1.282010000015.4255
Domestic EquitiesEQ - CONCORD BIOTECH LTD1.18136681114.2140
Domestic EquitiesEQ - ALEMBIC PHARMACEUTICALS1.093812050313.1613
Domestic EquitiesEQ - INDEGENE LTD1.033118220712.4311
Domestic EquitiesEQ - SANOFI CONSUMER HEALTHCARE INDIA LTD0.95422379211.4806
Domestic EquitiesEQ - ORCHID PHARMA LTD.0.92826662211.1688
Domestic EquitiesEQ - RAINBOW CHILDRENS MEDICARE LTD0.8173618709.8336
Domestic EquitiesEQ - POLY MEDICURE LTD0.7942343439.5563
Domestic EquitiesEQ - JUBILANT PHARMOVA LIMITED0.4810468895.7873
Domestic EquitiesEQ - STAR HEALTH & ALLIED INSURANCE0.39041000004.6975
Domestic EquitiesEQ- GLOBAL HEALTH LTD.0.3331372754.0076
Total 97.8812 1177.7325
Cash & Cash Equivalents and Net AssetsNET CURRENT ASSETS2.0045 24.1187
Total 2.0045 24.1187
Treasury Bills364 DAYS T - BILL- 06/02/20250.1068130000001.2848
Total 0.1068 1.2848
Deposits (Placed as Margin)CLEARING CORPORATION OF INDIA LTD. STD - MARGIN0.007500.0900
Total 0.0075 0.0900
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.